Clinical Trials
28 trialsCardioTox
Hospital Sirio-Libanes
CardioProtEx
Technical University of Madrid
PROTECT
Fondazione IRCCS Policlinico San Matteo di Pavia
HER-SAFE
University College, London
SPIROTOX
University of Sao Paulo
Strategy Therapy on Cancer Therapy-Related Cardiac Dysfunction
National Cheng-Kung University Hospital
CONTROL
Humanitas Hospital, Italy
The Safety Management of Cardiac Toxicity in Breast Cancer Patients Under Multidiscipline Therapy.
Ruijin Hospital
EDIPE
Institut de cancérologie Strasbourg Europe
Role of Silymarin in Chemotherapy Toxicity and Cognition Improvement in Breast Cancer Patients
Tanta University
The Impact of Chronic Mitochondrial Antioxidant Supplementation on CardiovascularToxicity in Breast Cancer Patients
D'Or Institute for Research and Education
SPARE-HF
University Health Network, Toronto
SAFE
Azienda Ospedaliero-Universitaria Careggi
Exercise Prescription Guided by Heart Rate Variability in Breast Cancer Patients
GO fit Lab- Ingesport
Effect of Trimetazidine on Radiotherapy-induced Heart Damage.
Peking University Third Hospital
CANFLAX
St. Boniface Hospital
Exercise Response After Revalidation in Cancer Patients
Universitair Ziekenhuis Brussel
Strain vs. Left Ventricular Ejection Fraction-based Cardiotoxicity Prevention in Breast Cancer
Samsung Medical Center
ERIC-ONC
University College, London
Effect of Angiotensin Converting Enzyme and Sacubitril Valsartan in Patients After Bone Marrow Transplantation
University of Athens
Ivabradine to Prevent Anthracycline-induced Cardiotoxicity
Vilnius University
Effect of Physical Training in Patients With Heart Failure Caused by Chemotherapy for Cancer Treatment
University of Sao Paulo General Hospital
Effectiveness of Using Biomarkers to Detect and Identify Cardiotoxicity and Describe Treatment (PREDICT)
M.D. Anderson Cancer Center
IPAC
University of Sao Paulo
COBC
Karolinska University Hospital
Study to See Whether Breath-Hold Techniques During RT Are Effective in Helping to Improve Sparing of the Heart
AHS Cancer Control Alberta
MANTICORE
AHS Cancer Control Alberta
Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Nonmetastatic Breast Cancer
National Cancer Institute (NCI)